Literature DB >> 29738786

Production of pure drug nanocrystals and nano co-crystals by confinement methods.

Flavia Fontana1, Patrícia Figueiredo1, Pei Zhang1, Jouni T Hirvonen1, Dongfei Liu2, Hélder A Santos3.   

Abstract

The use of drug nanocrystals in the drug formulation is increasing due to the large number of poorly water-soluble drug compounds synthetized and due to the advantages brought by the nanonization process. The downsizing processes are done using a top-down approach (milling and homogenization currently employed at the industrial level), while the crystallization process is performed by bottom-up techniques (e.g., antisolvent precipitation, use of supercritical fluids or spray and freeze drying). In addition, the production of nanocrystals in confined environment can be achieved within microfluidics channels. This review analyzes the processes for the preparation of nanocrystals and co-crystals, divided by top-down and bottom-up approaches, together with their combinations. The combination of both strategies merges the favorable features of each process and avoids the disadvantages of single processes. Overall, the applicability of drug nanocrystals is highlighted by the widespread research on the production processes at the engineering, pharmaceutical, and nanotechnology level.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bottom-up; Co-crystals; Drug; Homogenization; Microfluidics; Milling; Nanocrystals; Spray dryer; Supercritical fluids; Top-down

Mesh:

Substances:

Year:  2018        PMID: 29738786     DOI: 10.1016/j.addr.2018.05.002

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  17 in total

Review 1.  Liquid antisolvent crystallization of pharmaceutical compounds: current status and future perspectives.

Authors:  Rahul Kumar; Amit K Thakur; Nilanjana Banerjee; Ashutosh Kumar; Gajendra Kumar Gaurav; Raj Kumar Arya
Journal:  Drug Deliv Transl Res       Date:  2022-08-11       Impact factor: 5.671

2.  Using Amphiphilic Polymer Micelles as the Templates of Antisolvent Crystallization to Produce Drug Nanocrystals.

Authors:  Jianghao Zhang; Boxuan Lou; Xiaolan Qin; Yinwen Li; Haikuan Yuan; Lijuan Zhang; Xijian Liu; Yan Zhang; Jie Lu
Journal:  ACS Omega       Date:  2022-06-07

3.  A mitochondria-targeting lipid-small molecule hybrid nanoparticle for imaging and therapy in an orthotopic glioma model.

Authors:  Menghuan Tang; Kai Lin; Mythili Ramachandran; Longmeng Li; Hongye Zou; Huzhi Zheng; Zhao Ma; Yuanpei Li
Journal:  Acta Pharm Sin B       Date:  2022-04-14       Impact factor: 14.903

Review 4.  Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability.

Authors:  Maria Rosa Gigliobianco; Cristina Casadidio; Roberta Censi; Piera Di Martino
Journal:  Pharmaceutics       Date:  2018-08-21       Impact factor: 6.321

Review 5.  Advanced modification of drug nanocrystals by using novel fabrication and downstream approaches for tailor-made drug delivery.

Authors:  Tao Liu; Xinxin Yu; Haipeng Yin; Jan P Möschwitzer
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

6.  Oral delivery of carrier-free dual-drug nanocrystal self-assembled microspheres improved NAD+ bioavailability and attenuated cardiac ischemia/reperfusion injury in mice.

Authors:  Hongfei Nie; Yarong Zhang; Haiyang Yu; Hong Xiao; Tao Li; Qian Yang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

7.  Excipient-Free Pure Drug Nanoparticles Fabricated by Microfluidic Hydrodynamic Focusing.

Authors:  Roni Sverdlov Arzi; Asaf Kay; Yulia Raychman; Alejandro Sosnik
Journal:  Pharmaceutics       Date:  2021-04-10       Impact factor: 6.321

8.  In vitro - in vivo - in silico approach in the development of inhaled drug products: Nanocrystal-based formulations with budesonide as a model drug.

Authors:  Changzhi Shi; Jelisaveta Ignjatović; Tingting Liu; Meihua Han; Dongmei Cun; Jelena Đuriš; Mingshi Yang; Sandra Cvijić
Journal:  Asian J Pharm Sci       Date:  2021-01-05       Impact factor: 6.598

9.  Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation.

Authors:  Sha Xiong; Wei Liu; Yile Zhou; Yousheng Mo; Yao Liu; Xiaojia Chen; Huafeng Pan; Dongsheng Yuan; Qi Wang; Tongkai Chen
Journal:  Asian J Pharm Sci       Date:  2019-05-24       Impact factor: 6.598

10.  Preparation of parenteral nanocrystal suspensions of etoposide from the excipient free dry state of the drug to enhance in vivo antitumoral properties.

Authors:  Brice Martin; Johanne Seguin; Maxime Annereau; Thomas Fleury; René Lai-Kuen; Giovanni Neri; Anita Lam; Marcel Bally; Nathalie Mignet; Yohann Corvis
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.